Amgen boasts Horizon sales, investments in obesity market | Pacific Coast Business Times
Amgen's new research and development facility in San Francisco. (courtesy photo) It took nearly a year, but the impact of Amgen’s historic purchase of Horizon Therapeutics was finally felt on Feb. 6 when the company disclosed its earnings for the fourth quarter and full year 2023. Amgen, one of the largest biotechnology companies in the